Stephen R. Thomas

ORCID: 0000-0003-2368-8058
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Particle Detector Development and Performance
  • Advanced MRI Techniques and Applications
  • SARS-CoV-2 and COVID-19 Research
  • Radiation Dose and Imaging
  • Medical Imaging Techniques and Applications
  • COVID-19 Clinical Research Studies
  • Radiation Detection and Scintillator Technologies
  • Radiopharmaceutical Chemistry and Applications
  • CCD and CMOS Imaging Sensors
  • Neuroscience and Neuropharmacology Research
  • Advanced Radiotherapy Techniques
  • Advanced X-ray and CT Imaging
  • Pneumonia and Respiratory Infections
  • Radiation Effects in Electronics
  • Electron Spin Resonance Studies
  • Diabetes Management and Research
  • Respiratory viral infections research
  • Asthma and respiratory diseases
  • Nuclear Physics and Applications
  • Cardiac Imaging and Diagnostics
  • Bacterial Infections and Vaccines
  • Atomic and Subatomic Physics Research
  • Tuberculosis Research and Epidemiology
  • Memory and Neural Mechanisms
  • Bacteriophages and microbial interactions

Istituto Nazionale di Fisica Nucleare, Sezione di Bari
2024

UK Health Security Agency
2021-2023

Public Health England
2015-2021

Guy's Hospital
2021

Raigmore Hospital
2018-2021

NHS Highland
2020-2021

Bristol Royal Infirmary
2020

SUNY Upstate Medical University
2019

Fermi National Accelerator Laboratory
2019

Rutherford Appleton Laboratory
1999-2018

Adjustments of the standard helical CT protocols for adults can result in reduced radiation dose when imaging children. It is radiologist's responsibility to critically evaluate techniques used at their institution. should be made choose appropriate mA and pitch

10.2214/ajr.176.2.1760303 article EN American Journal of Roentgenology 2001-02-01
Miles W. Carroll David A. Matthews Julian A. Hiscox Michael J. Elmore Georgios Pollakis and 95 more Andrew Rambaut Roger Hewson Isabel García-Dorival Joseph Akoi Boré Raymond Koundouno Saïd Abdellati Babak Afrough John Aiyepada Patience Akhilomen Danny Asogun Barry Atkinson Marlis Badusche Amadou Bah Simon Bate Jan Baumann Dirk Becker Beate Becker‐Ziaja Anne Bocquin Benny Borremans Andrew Bosworth Jan Peter Boettcher Angela Cannas Fabrizio Carletti Concetta Castilletti Simon Clark Francesca Colavita Sandra Diederich Adomeh Donatus Sophie Duraffour Deborah U. Ehichioya Heinz Ellerbrok María Dolores Fernández-García Alexandra Fizet Erna Fleischmann Sophie Gryseels Antje Hermelink Julia Hinzmann Ute Hopf-Guevara Yemisi Ighodalo Lisa Jameson Anne Kelterbaum Zoltán Kis Stefan Kloth Claudia Kohl Miša Korva Annette Kraus Eeva Kuisma Andreas Kurth Britta Liedigk Christopher H. Logue Anja Lüdtke Piet Maes James W. I. McCowen Stéphane Mély Marc Mertens Silvia Meschi Benjamin Meyer Janine Michel Peter Molkenthin César Muñoz‐Fontela Doreen Muth Edmund Newman Didier Ngabo Lisa Oestereich Jennifer Okosun Thomas Olokor Racheal Omiunu Emmanuel Omomoh Elisa Pallasch Bernadett Pályi Jasmine Portmann Thomas Pottage Catherine Pratt Simone Priesnitz Serena Quartu Julie C. F. Rappe Johanna Repits Martin Richter Martin Rudolf Andreas Sachse Kristina M. Schmidt Gordian Schudt Thomas Strecker Ruth Thom Stephen R. Thomas Ekaete Tobin H. Dennis Tolley Jochen Trautner Tine Vermoesen Inês Vitoriano Matthias Wagner Svenja Wolff Constanze Yue Maria Rosaria Capobianchi Birte Kretschmer

Analysis of 179 new Ebola virus sequences from patient samples collected in Guinea between March 2014 and January 2015 shows how different lineages evolved spread West Africa. Miles Carroll colleagues report describe the genetic evolution circulating Africa, based on 2015. Their analysis Africa Sierra Leone, Liberia. is currently witnessing most extensive (EBOV) outbreak so far recorded1,2,3. Until now, there have been 27,013 reported cases 11,134 deaths. The origin thought to a zoonotic...

10.1038/nature14594 article EN cc-by-nc-sa Nature 2015-06-17

There is a vital need for authentic COVID-19 animal models to enable the pre-clinical evaluation of candidate vaccines and therapeutics. Here we report dose titration study SARS-CoV-2 in ferret model. After high (5 × 106 pfu) medium 104 virus delivered, intranasally, viral RNA shedding upper respiratory tract (URT) observed 6/6 animals, however, only 1/6 ferrets show similar signs after low 102 challenge. Following sequential culls pathological mild multifocal bronchopneumonia approximately...

10.1038/s41467-020-20439-y article EN cc-by Nature Communications 2021-01-04

A novel coronavirus, SARS-CoV-2, has been identified as the causative agent of current COVID-19 pandemic. Animal models, and in particular non-human primates, are essential to understand pathogenesis emerging diseases assess safety efficacy vaccines therapeutics. Here, we show that SARS-CoV-2 replicates upper lower respiratory tract causes pulmonary lesions both rhesus cynomolgus macaques. Immune responses against also similar species equivalent those reported milder infections convalescent...

10.1038/s41467-021-21389-9 article EN cc-by Nature Communications 2021-02-24

Renal toxicity associated with small-molecule radionuclide therapy has been shown to be dose-limiting for many clinical studies. Strategies maximizing dose the target tissues while sparing normal critical organs based on absorbed and biologic response parameters are commonly used in external-beam therapy. However, radiopharmaceuticals passing though kidneys result a differential rate suborgan elements, presenting significant challenge assessing an accurate dose–response relationship that is...

10.2967/jnumed.108.053173 article EN Journal of Nuclear Medicine 2008-10-16

BackgroundThe novel human coronavirus SARS-CoV-2 is a major ongoing global threat with huge economic burden. Like all respiratory viruses, initiates infection in the upper tract (URT). Infected individuals are often asymptomatic, yet highly infectious and readily transmit virus. A therapy that restricts initial replication URT has potential to prevent progression of severe lower disease as well limiting person-to-person transmission.MethodsSARS-CoV-2 Victoria/01/2020 was passaged Vero/hSLAM...

10.1016/j.ebiom.2020.103153 article EN cc-by-nc-nd EBioMedicine 2020-12-03

BackgroundSARS-CoV-2 serology is used to identify prior infection at individual and population level. Extended longitudinal studies with multi-timepoint sampling evaluate dynamic changes in antibody levels are required the time horizon which these applications of valid, explore longevity protective humoral immunity.MethodsHealthcare workers were recruited a prospective cohort study from first SARS-CoV-2 epidemic peak London, undergoing weekly symptom screen, viral PCR blood over 16–21 weeks....

10.1016/j.ebiom.2021.103259 article EN cc-by EBioMedicine 2021-03-01

Rhenium-186(tin) hydroxyethylidene diphosphonate (HEDP) is a new radiopharmaceutical that localizes in areas of osseous metastases manner similar to standard bone-scanning agents. It also emits beta particles with sufficient energy be therapeutically useful. A single intravenous injection about 33 mCi (1,221 MBq) was given each 20 elderly patients advanced skeletal from hormonally resistant prostate cancer. Prompt, significant relief pain occurred 80% the time no side effects and only...

10.1148/radiology.176.1.1693784 article EN Radiology 1990-07-01

The mutation profile of the SARS-CoV-2 Omicron (lineage BA.1) variant posed a concern for naturally acquired and vaccine-induced immunity. We investigated ability prior infection with an early ancestral isolate (Australia/VIC01/2020, VIC01) to protect against disease caused by BA.1. established that BA.1 in naïve Syrian hamsters resulted less severe than comparable dose virus, fewer clinical signs including weight loss. present data show these observations were almost absent convalescent...

10.1371/journal.ppat.1011293 article EN cc-by PLoS Pathogens 2023-04-04

10.1016/j.nima.2024.169682 article EN Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment 2024-08-02

Certain perfluorocarbon (PFC) compounds, commonly used as the oxygen transport components of "blood substitutes," may be breathed neat liquids with survival because their chemical inertness and high solubility for carbon dioxide. In addition, paramagnetism reduces fluorine T1 value according to an inverse relationship allowing a potential method monitoring Po2 gradients in vivo. This article presents results magnetic resonance (MR) imaging lungs mice rats following breathing four PFC (FC-43,...

10.1097/00004728-198601000-00001 article EN Journal of Computer Assisted Tomography 1986-01-01

We report 2 cases of Ebola viral disease (EVD) in pregnant women who survived, initially with intact pregnancies. Respectively 31–32 days after negativation the maternal blood EVD-polymerase chain reaction (PCR) both patients delivered a stillborn fetus persistent EVD-PCR amniotic fluid positivity.

10.1093/cid/civ1024 article EN cc-by-nc-nd Clinical Infectious Diseases 2015-12-17

Abstract In December 2019 an outbreak of coronavirus disease (COVID-19) emerged in Wuhan, China. The causative agent was subsequently identified and named severe acute respiratory syndrome 2 (SARS-CoV-2) which rapidly spread worldwide causing a pandemic. Currently there are no licensed vaccines or therapeutics available against SARS-CoV-2 but numerous candidate development repurposed drugs being tested the clinic. There is vital need for authentic COVID-19 animal models to further our...

10.1101/2020.05.29.123810 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2020-05-29

We present the development and prototype test of LPD instrument, a novel pixel detector for European XFEL. At XFEL must be capable operating with frame rate 4.5MHz record images dynamic range 1:100,000 photons (12keV) whilst maintaining low noise. The system has large in memory depth 512 that can selected flexible veto system. Data is then transferred off head between pulses an accompanying high data acquisition been prototyped assembled into contains custom silicon sensors ASICs as well...

10.1109/nssmic.2012.6551165 article EN 2012-10-01
Coming Soon ...